AQMS
Aqua Metals, Inc.
There isn't enough reported data to score AQMS yet.
RKLB
Rocket Lab USA, Inc.
RKLB lost money over the past year, so it has no meaningful PE right now. Analysts expect losses to shrink, though they disagree widely on how much.
AQMS Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Under pressure | |
| Unavailable | |
| Unavailable |
AQMS's profitability is currently under pressure. There isn't enough data to rate its revenue, cash flow and balance sheet.
RKLB Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Under pressure | |
| Weak | |
| Unavailable |
RKLB's revenue is currently strong, but its profitability and cash flow are under pressure. There isn't enough data to rate its balance sheet.
AQMS PE Valuation
AQMS has no meaningful PE right now: it lost money over the past year.
RKLB PE Valuation
RKLB has no meaningful PE right now: it lost money over the past year.
AQMS Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses growing | |
| Strong decline | |
| -- | |
| Limited | |
| High |
Analysts expect AQMS's losses to grow, with revenue declining.
RKLB Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect RKLB's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
AQMS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | -$9.21 | +$26.83 |
| Q1 2026 | -$15.34 | +$23.26 |
| Q4 2025 | -$24.42 | +$13.88 |
| Q3 2025 | -$30.63 | +$18.32 |
| Q2 2025 | -$36.04 | +$13.31 |
| Q1 2025 | -$38.60 | +$12.75 |
| Q4 2024 | -$38.30 | +$15.05 |
| Q3 2024 | -$48.95 | -$6.48 |
AQMS has the edge over RKLB on earnings, with more consistent year-over-year improvement.
RKLB Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.36 | +$0.03 |
| Q2 2026 | -$0.27 | +$0.19 |
| Q1 2026 | -$0.32 | +$0.09 |
| Q4 2025 | -$0.37 | +$0.01 |
| Q3 2025 | -$0.39 | -$0.02 |
| Q2 2025 | -$0.46 | -$0.11 |
| Q1 2025 | -$0.41 | -$0.04 |
| Q4 2024 | -$0.38 | $0.00 |
RKLB is still losing money, but less than at its worst: $0.36 per share over the past year, against $0.46 at its worst in mid-2025.
AQMS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2020 | $90K | -96% |
RKLB has the stronger quarterly revenue trend. Revenue is down 100% for AQMS versus up 73% for RKLB.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2023 | -19796% | N/A |
| Q2 2022 | -98875% | N/A |
| Q4 2021 | -2428% | N/A |
| Q3 2020 | -3790% | -3313 points |
| Q1 2020 | -22572% | N/A |
| Q4 2019 | -1734% | N/A |
| Q3 2019 | -477% | N/A |
AQMS's operating margin was −19796% last quarter, up 2776 points from the same quarter a year ago.
RKLB Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $267.8M | +73% |
| Q2 2026 | $234.1M | +62% |
| Q1 2026 | $200.3M | +63% |
| Q4 2025 | $179.7M | +36% |
| Q3 2025 | $155.1M | +48% |
| Q2 2025 | $144.5M | +36% |
| Q1 2025 | $122.6M | +32% |
| Q4 2024 | $132.4M | +121% |
RKLB's revenue has grown year over year every quarter since late 2021: $268M last quarter, up 73% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -30% | +8.5 points |
| Q2 2026 | -25% | +17 points |
| Q1 2026 | -28% | +20 points |
| Q4 2025 | -28% | +11 points |
| Q3 2025 | -38% | +12 points |
| Q2 2025 | -41% | -0.5 points |
| Q1 2025 | -48% | -1.9 points |
| Q4 2024 | -39% | +41 points |
RKLB's operating margin was −30% last quarter, up 8.5 points from the same quarter a year ago.
AQMS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$2.6M | +$48K |
| Q1 2026 | -$3.8M | -$802K |
| Q4 2025 | -$2.6M | -$145K |
| Q3 2025 | -$2.3M | +$2.3M |
| Q2 2025 | -$2.7M | +$4.8M |
| Q1 2025 | -$3M | +$3.9M |
| Q4 2024 | -$2.5M | +$2.4M |
| Q3 2024 | -$4.6M | -$758K |
AQMS has the edge over RKLB on cash flow, with more consistent year-over-year improvement.
RKLB Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$23.9M | +$45.5M |
| Q2 2026 | -$110.1M | -$54.8M |
| Q1 2026 | -$77.4M | +$5.5M |
| Q4 2025 | -$114.2M | -$90.2M |
| Q3 2025 | -$69.4M | -$27.5M |
| Q2 2025 | -$55.3M | -$26.9M |
| Q1 2025 | -$82.9M | -$61.1M |
| Q4 2024 | -$23.9M | +$28.7M |
RKLB has burned cash in almost every quarter: −$326M over the past year, against −$232M the year before.
AQMS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +5.3% | +172K shares |
| 1 year | +321% | +2.6M shares |
| 3 years | +799% | +3M shares |
| 5 years | +997% | +3.1M shares |
| Available history | +1095% | +3.1M shares |
AQMS has 3M diluted shares, up 321% from a year ago.
RKLB Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +3.6% | +22.6M shares |
| 1 year | +23% | +124M shares |
| 3 years | +35% | +168M shares |
| 5 years | +46% | +204M shares |
RKLB has the edge over AQMS on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q4 2020 | — |
| Q2 2020 | — |
| Q1 2020 | — |
AQMS Net Leverage
AQMS's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
RKLB Net Leverage
RKLB's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
AQMS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 31.8 | Neutral |
| Stochastic | 11.6 | Oversold |
AQMS's weekly RSI is 32 (neutral) and its Stochastic is 12 (oversold).
RKLB Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 46.8 | Neutral |
| Stochastic | 27.6 | Neutral |
RKLB's weekly RSI is 47 (neutral) and its Stochastic is 28 (neutral).
AQMS PE vs Industrials Sector
AQMS has no meaningful PE right now: it lost money over the past year.
RKLB PE vs Industrials Sector
RKLB has no meaningful PE right now: it lost money over the past year.
AQMS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1.77 | 23% below |
| 20 week MA | $2.32 | 41% below |
| 50 week MA | $3.70 | 63% below |
| 100 week MA | $7.76 | 82% below |
| 200 week MA | $75.2 | 98% below |
AQMS is in a downtrend: it's below all five of its weekly moving averages, and 98% below its 200-week average.
RKLB Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $61.4 | 4.3% above |
| 20 week MA | $68.1 | 5.9% below |
| 50 week MA | $77.6 | 17% below |
| 100 week MA | $56.5 | 13% above |
| 200 week MA | $31.4 | 104% above |
RKLB has the edge over AQMS on trend strength, trading above more of its moving averages.
AQMS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $166.0 | $468.0 | +182% |
| 2021 | $468.0 | $276.0 | -41% |
| 2022 | $276.0 | $148.0 | -46% |
| 2023 | $148.0 | $152.0 | +2.7% |
| 2024 | $152.0 | $26.2 | -83% |
| 2025 | $26.2 | $4.85 | -81% |
| 2026 YTD | $4.85 | $1.37 | -72% |
AQMS's yearly returns have swung widely, from +182% in 2020 to −83% in 2024. It's down 72% so far in 2026.
RKLB Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.82 | $10.3 | +4.9% |
| 2021 | $10.3 | $12.0 | +17% |
| 2022 | $12.0 | $3.77 | -69% |
| 2023 | $3.77 | $5.53 | +47% |
| 2024 | $5.53 | $27.2 | +392% |
| 2025 | $27.2 | $70.7 | +160% |
| 2026 YTD | $70.7 | $64.1 | -9.3% |
RKLB has the edge over AQMS on returns for 2026, with the stronger performance.